Researchers at Dal, UMantioba moving to test COVID-19 vaccine, treatments

March 27, 2020

Researchers at Dalhousie University and the University of Manitoba are preparing to enter trials for COVID-19 treatments and vaccines. Dal researchers are moving forward with testing a vaccine that uses a genome of DNA from SARS CoV-2. "We're working as hard as we can to move this as fast as possible," said Dal Professor Alyson Kelvin. "We have other vaccines in the pipeline in case this isn't the best vaccine that we can put forth." Meanwhile, UManitoba researchers are testing if hydroxychloroquine — a drug approved by Health Canada to prevent and treat malaria since the 1950s — can be repurposed to reduce the severity of COVID-19. "The idea is to reduce the severity of symptoms," said UManitoba Professor Ryan Zarychanski, "and also reduce the transmissibility of the virus and reduce community spread, which can help keep our population more healthy and reduce the burden that we're expecting on the healthcare system." CBC (1) | CBC (2) (NS, MB)